Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers-Reference-Cited by-同舟云学术

Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers

Published:2018-08-25 Issue:9 Volume:93 Page:E243-E246
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Barcellini Wilma¹^ORCID,Zaninoni Anna¹^ORCID,Fattizzo Bruno¹^ORCID,Giannotta Juri Alessandro¹,Lunghi Monia²,Ferrari Antonella³,Leporace Anna Paola³,Maschio Nilla⁴,Scaramucci Laura⁵,Cantoni Silvia⁶,Chiurazzi Federico⁷,Consonni Dario⁸,Rossi Giuseppe⁹,De Fabritiis Paolo⁵,Gaidano Gianluca²,Zanella Alberto¹,Cortelezzi Agostino¹¹⁰

Affiliation:

1. UO Ematologia; Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico; Milan Italy

2. SCDU Ematologia, Dipartimento di Medicina Traslazionale; Università del Piemonte Orientale Amedeo Avogadro; Novara Italy

3. UO Ematologia, Ospedale Sant'Andrea; Facoltà di Medicina e Psicologia, Università "Sapienza"; Rome Italy

4. UO Trasfusionale e immunologia; Centro Regionale Malattie del Sangue; Castelfranco Veneto Italy

5. UO Ematologia; Ospedale S. Eugenio; Rome Italy

6. SC Ematologia; Niguarda Cancer Center, ASST Niguarda; Milan Italy

7. Ematologia; Università degli Studi di Napoli Federico II; Napoli Italy

8. UO Epidemiologia; Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico; Milan Italy

9. SC Ematologia; Spedali Civili di Brescia; Brescia Italy

10. Università degli Studi di Milano; Milan Italy

Funder

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.25212/fullpdf

Reference6 articles.

1. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients;Barcellini;Blood,2014

2. Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias;Fattizzo;Am J Hematol,2015

3. Current treatment strategies in autoimmune hemolytic disorders;Barcellini;Expert Rev Hematol,2015

4. How I treat autoimmune hemolytic anemia;Go;Blood,2017

5. How I manage patients with cold agglutinin disease;Berentsen;Br J Haematol,2018

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Hemolytic Anemias: Challenges in Diagnosis and Therapy;Transfusion Medicine and Hemotherapy;2024-08-27

2. The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease;Expert Review of Hematology;2024-06-13

3. Plasma exchange is the hope for critically ill children with life-threatening autoimmune hemolytic anemia;Egyptian Pediatric Association Gazette;2024-05-29

4. Add-on erythropoietin in autoimmune hemolytic anemia;Blood Advances;2024-03-12

5. Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab;Annals of Hematology;2024-02-01